Dr. Michael J. Blaha, MD, MPH (Professor of Cardiology and Epidemiology), represents the 4th generation of physicians in his family. He practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. He has mentored over 30 trainees, many of whom have gone on to hold prominent academic appointments.
Dr. Blaha has published over 550 scientific articles focusing on the appropriate use of tests and new therapies in the prevention of atherosclerotic cardiovascular disease. He has received multiple grant awards from the National Institutes of Health, FDA, American Heart Association, Amgen Foundation, Aetna Foundation, Bayer, and Novo Nordisk.
